BRIEF-Fibrogen Announces Sale Of Fibrogen China To Astrazeneca For About $160 Million

-0.51%

-3.68%

-0.51%

-1.07%

-1.69%

Astrazeneca PLC Sponsored ADR AZN	89.83	-0.51%
FibroGen, Inc. FGEN	8.38	-3.68%
Dow Jones Industrial Average DJI	48458.05	-0.51%
S&P 500 index SPX	6827.41	-1.07%
NASDAQ IXIC	23195.17	-1.69%

Feb 20 (Reuters) - FibroGen Inc FGEN.O:

FIBROGEN ANNOUNCES THE SALE OF FIBROGEN CHINA TO ASTRAZENECA FOR APPROXIMATELY $160 MILLION
FIBROGEN INC - ANNOUNCES SALE OF CHINA SUBSIDIARY TO ASTRAZENECA FOR $160 MILLION
FIBROGEN INC - CASH RUNWAY EXTENDED INTO 2027

Source text: ID:nGNXtnJ8x

Further company coverage: FGEN.O

((Reuters.Briefs@thomsonreuters.com;))

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.